Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Induction of the Immunoproteasome Subunit Lmp7 Links Proteostasis and Immunity in α-Synuclein Aggregation Disorders.

EBioMedicine | 2018

Accumulation of aggregated α-synuclein into Lewy bodies is thought to contribute to the onset and progression of dopaminergic neuron degeneration in Parkinson's disease (PD) and related disorders. Although protein aggregation is associated with perturbation of proteostasis, how α-synuclein aggregation affects the brain proteome and signaling remains uncertain. In a mouse model of α-synuclein aggregation, 6% of 6215 proteins and 1.6% of 8183 phosphopeptides changed in abundance, indicating conservation of proteostasis and phosphorylation signaling. The proteomic analysis confirmed changes in abundance of proteins that regulate dopamine synthesis and transport, synaptic activity and integrity, and unearthed changes in mRNA binding, processing and protein translation. Phosphorylation signaling changes centered on axonal and synaptic cytoskeletal organization and structural integrity. Proteostatic responses included a significant increase in the levels of Lmp7, a component of the immunoproteasome. Increased Lmp7 levels and activity were also quantified in postmortem human brains with PD and dementia with Lewy bodies. Functionally, the immunoproteasome degrades α-synuclein aggregates and generates potentially antigenic peptides. Expression and activity of the immunoproteasome may represent testable targets to induce adaptive responses that maintain proteome integrity and modulate immune responses in protein aggregation disorders.

Pubmed ID: 29759483 RIS Download

Research resources used in this publication

Associated grants

  • Agency: NIA NIH HHS, United States
    Id: R01 AG013966
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS088322
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM008076
  • Agency: NICHD NIH HHS, United States
    Id: U54 HD086984

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


BioVision (tool)

RRID:SCR_005057

An Antibody supplier

View all literature mentions

Thermo Fisher Scientific (tool)

RRID:SCR_008452

Commercial vendor and service provider of laboratory reagents and antibodies. Supplier of scientific instrumentation, reagents and consumables, and software services.

View all literature mentions

Cell Signaling Technology (tool)

RRID:SCR_004431

Privately held company that develops and produces antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents used to study cell signaling pathways that impact human health.

View all literature mentions

ProteomeXchange (tool)

RRID:SCR_004055

A data repository for proteomic data sets. The ProteomeExchange consortium, as a whole, aims to provide a coordinated submission of MS proteomics data to the main existing proteomics repositories, as well as to encourage optimal data dissemination. ProteomeXchange provides access to a number of public databases, and users can access and submit data sets to the consortium's PRIDE database and PASSEL/PeptideAtlas.

View all literature mentions

NEURON (tool)

RRID:SCR_005393

NEURON is a simulation environment for modeling individual neurons and networks of neurons. It provides tools for conveniently building, managing, and using models in a way that is numerically sound and computationally efficient. It is particularly well-suited to problems that are closely linked to experimental data, especially those that involve cells with complex anatomical and biophysical properties. NEURON has benefited from judicious revision and selective enhancement, guided by feedback from the growing number of neuroscientists who have used it to incorporate empirically-based modeling into their research strategies. NEURON's computational engine employs special algorithms that achieve high efficiency by exploiting the structure of the equations that describe neuronal properties. It has functions that are tailored for conveniently controlling simulations, and presenting the results of real neurophysiological problems graphically in ways that are quickly and intuitively grasped. Instead of forcing users to reformulate their conceptual models to fit the requirements of a general purpose simulator, NEURON is designed to let them deal directly with familiar neuroscience concepts. Consequently, users can think in terms of the biophysical properties of membrane and cytoplasm, the branched architecture of neurons, and the effects of synaptic communication between cells. * helps users focus on important biological issues rather than purely computational concerns * has a convenient user interface * has a user-extendable library of biophysical mechanisms * has many enhancements for efficient network modeling * offers customizable initialization and simulation flow control * is widely used in neuroscience research by experimentalists and theoreticians * is well-documented and actively supported * is free, open source, and runs on (almost) everything

View all literature mentions

Millipore (tool)

RRID:SCR_008983

An Antibody supplier

View all literature mentions

Program to Reduce Incontinence by Diet and Exercise (tool)

RRID:SCR_009018

Randomized controlled trial being conducted at two clinical centers in the United States to learn more about the effects of weight loss on urinary incontinence. About 330 overweight women aged 30 or older will participate and will be followed for 18 months. Efficacy of weight reduction as a treatment for urinary incontinence will be examined at 6 months following the intensive weight control program, and the sustained impact of the intervention will be examined at 18 months. To increase the maintenance of weight reduction and facilitate evaluation of the enduring impact of weight loss on urinary incontinence, they propose to study a motivation-based weight maintenance program. At the end of the intensive weight control program, women randomized to the weight loss program will be randomized to either a 12-month skill-based maintenance intervention or to a motivation-based maintenance intervention. The maintenance interventions maximize the potential for sustained weight loss and will allow them to determine if long-term weight reduction will produce continued improvement in urinary incontinence.

View all literature mentions

MaxQuant (tool)

RRID:SCR_014485

A quantitative proteomics software package for analyzing large-scale mass-spectrometric data sets. It is a set of algorithms that include peak detection and scoring of peptides, mass calibration, database searches for protein identification, protein quantification, and provides summary statistics.

View all literature mentions

C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions

U-251MG (tool)

RRID:CVCL_0021

Cell line U-251MG is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

NSE antibody (antibody)

RRID:AB_881756

This polyclonal targets NSE antibody

View all literature mentions

Iba1 antibody (antibody)

RRID:AB_2224402

This polyclonal targets AIF1

View all literature mentions

PSMB5 Polyclonal Antibody (antibody)

RRID:AB_2172052

This unknown targets PSMB5

View all literature mentions

alpha-Synuclein (D37A6) XP Rabbit mAb (antibody)

RRID:AB_1904156

This monoclonal targets alpha-Synuclein (D37A6) XP Rabbit mAb

View all literature mentions

Akt Antibody (antibody)

RRID:AB_329827

This polyclonal targets Akt

View all literature mentions

PKC beta 2 antibody [Y125] (antibody)

RRID:AB_779042

This monoclonal targets PKC beta 2

View all literature mentions

DOPA Decarboxylase antibody (antibody)

RRID:AB_304145

This polyclonal targets DOPA Decarboxylase

View all literature mentions

MAB369 | Anti-Dopamine Transporter Antibody, NT, clone DAT-Nt (antibody)

RRID:AB_2190413

This monoclonal targets Dopamine Transporter N-terminus clone DAT-Nt

View all literature mentions

Anti-Tyrosine Hydroxylase Rabbit pAb (antibody)

RRID:AB_696697

This polyclonal targets Tyrosine Hydroxylase Rabbit pAb

View all literature mentions

UniProt (data or information resource)

RRID:SCR_002380

Collection of data of protein sequence and functional information. Resource for protein sequence and annotation data. Consortium for preservation of the UniProt databases: UniProt Knowledgebase (UniProtKB), UniProt Reference Clusters (UniRef), and UniProt Archive (UniParc), UniProt Proteomes. Collaboration between European Bioinformatics Institute (EMBL-EBI), SIB Swiss Institute of Bioinformatics and Protein Information Resource. Swiss-Prot is a curated subset of UniProtKB.

View all literature mentions

Gene Ontology Tools (software resource)

RRID:SCR_006941

Collection of tools developed by GO Consortium and by third parties. Tools are listed by category or alphabetically and continue to be improved and expanded.

View all literature mentions

DAVID (software resource)

RRID:SCR_001881

Bioinformatics resource system including web server and web service for functional annotation and enrichment analyses of gene lists. Consists of comprehensive knowledgebase and set of functional analysis tools. Includes gene centered database integrating heterogeneous gene annotation resources to facilitate high throughput gene functional analysis.

View all literature mentions

GeneMANIA (software resource)

RRID:SCR_005709

Data analysis service to predict the function of your favorite genes and gene sets. Indexing 1,421 association networks containing 266,984,699 interactions mapped to 155,238 genes from 7 organisms. GeneMANIA interaction networks are available for download in plain text format. GeneMANIA finds other genes that are related to a set of input genes, using a very large set of functional association data. Association data include protein and genetic interactions, pathways, co-expression, co-localization and protein domain similarity. You can use GeneMANIA to find new members of a pathway or complex, find additional genes you may have missed in your screen or find new genes with a specific function, such as protein kinases. Your question is defined by the set of genes you input. If members of your gene list make up a protein complex, GeneMANIA will return more potential members of the protein complex. If you enter a gene list, GeneMANIA will return connections between your genes, within the selected datasets. GeneMANIA suggests annotations for genes based on Gene Ontology term enrichment of highly interacting genes with the gene of interest. GeneMANIA is also a gene recommendation system. GeneMANIA is also accessible via a Cytoscape plugin, designed for power users. Platform: Online tool, Windows compatible, Mac OS X compatible, Linux compatible, Unix compatible

View all literature mentions

Motif Extractor (software resource)

RRID:SCR_008628

motif-x (short for motif extractor) is a software tool designed to extract overrepresented patterns from any sequence data set. The algorithm is an iterative strategy which builds successive motifs through comparison to a dynamic statistical background.

View all literature mentions

Iba1 antibody (antibody)

RRID:AB_2224402

This polyclonal targets AIF1

View all literature mentions

PSMB5 Polyclonal Antibody (antibody)

RRID:AB_2172052

This unknown targets PSMB5

View all literature mentions

alpha-Synuclein (D37A6) XP Rabbit mAb (antibody)

RRID:AB_1904156

This monoclonal targets alpha-Synuclein (D37A6) XP Rabbit mAb

View all literature mentions

Akt Antibody (antibody)

RRID:AB_329827

This polyclonal targets Akt

View all literature mentions

PKC beta 2 antibody [Y125] (antibody)

RRID:AB_779042

This monoclonal targets PKC beta 2

View all literature mentions

DOPA Decarboxylase antibody (antibody)

RRID:AB_304145

This polyclonal targets DOPA Decarboxylase

View all literature mentions

MAB369 | Anti-Dopamine Transporter Antibody, NT, clone DAT-Nt (antibody)

RRID:AB_2190413

This monoclonal targets Dopamine Transporter N-terminus clone DAT-Nt

View all literature mentions

Anti-Tyrosine Hydroxylase Rabbit pAb (antibody)

RRID:AB_696697

This polyclonal targets Tyrosine Hydroxylase Rabbit pAb

View all literature mentions

Iba1 antibody (antibody)

RRID:AB_2224402

This polyclonal targets AIF1

View all literature mentions

PSMB5 Polyclonal Antibody (antibody)

RRID:AB_2172052

This unknown targets PSMB5

View all literature mentions

alpha-Synuclein (D37A6) XP Rabbit mAb (antibody)

RRID:AB_1904156

This monoclonal targets alpha-Synuclein (D37A6) XP Rabbit mAb

View all literature mentions

Akt Antibody (antibody)

RRID:AB_329827

This polyclonal targets Akt

View all literature mentions

PKC beta 2 antibody [Y125] (antibody)

RRID:AB_779042

This monoclonal targets PKC beta 2

View all literature mentions

DOPA Decarboxylase antibody (antibody)

RRID:AB_304145

This polyclonal targets DOPA Decarboxylase

View all literature mentions

MAB369 | Anti-Dopamine Transporter Antibody, NT, clone DAT-Nt (antibody)

RRID:AB_2190413

This monoclonal targets Dopamine Transporter N-terminus clone DAT-Nt

View all literature mentions

Anti-Tyrosine Hydroxylase Rabbit pAb (antibody)

RRID:AB_696697

This polyclonal targets Tyrosine Hydroxylase Rabbit pAb

View all literature mentions

NSE antibody (antibody)

RRID:AB_881756

This polyclonal targets NSE antibody

View all literature mentions

NSE antibody (antibody)

RRID:AB_881756

This polyclonal targets NSE antibody

View all literature mentions

NSE antibody (antibody)

RRID:AB_881756

This polyclonal targets NSE antibody

View all literature mentions

NSE antibody (antibody)

RRID:AB_881756

This polyclonal targets NSE antibody

View all literature mentions